A detailed history of Bridgeway Capital Management, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 185,563 shares of MRK stock, worth $18.2 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
185,563
Previous 160,952 15.29%
Holding current value
$18.2 Million
Previous $19.9 Million 5.76%
% of portfolio
0.47%
Previous 0.48%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $2.74 Million - $3.17 Million
24,611 Added 15.29%
185,563 $21.1 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $1.61 Million - $1.73 Million
13,021 Added 8.8%
160,952 $19.9 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $573,220 - $667,930
-5,062 Reduced 3.31%
147,931 $19.5 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $3.46 Million - $3.77 Million
34,562 Added 29.18%
152,993 $16.7 Million
Q3 2023

Nov 14, 2023

BUY
$102.95 - $114.33 $886,399 - $984,381
8,610 Added 7.84%
118,431 $12.2 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $8.88 Million - $9.68 Million
81,786 Added 291.73%
109,821 $12.7 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $180,145 - $201,005
-1,750 Reduced 5.88%
28,035 $2.98 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $2.5 Million - $3.21 Million
-28,600 Reduced 48.99%
29,785 $3.3 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $2.6 Million - $2.92 Million
-30,700 Reduced 34.46%
58,385 $5.03 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $2.88 Million - $3.27 Million
-34,500 Reduced 27.92%
89,085 $8.12 Million
Q1 2022

May 16, 2022

SELL
$73.51 - $82.4 $797,583 - $894,040
-10,850 Reduced 8.07%
123,585 $10.1 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $14.8 Million - $18.6 Million
-205,400 Reduced 60.44%
134,435 $10.3 Million
Q3 2021

Nov 15, 2021

SELL
$71.68 - $78.83 $2.76 Million - $3.03 Million
-38,500 Reduced 10.18%
339,835 $25.5 Million
Q2 2021

Aug 16, 2021

BUY
$70.31 - $77.77 $42,186 - $46,662
600 Added 0.16%
378,335 $29.4 Million
Q1 2021

May 17, 2021

BUY
$68.86 - $81.11 $2.31 Million - $2.73 Million
33,600 Added 9.76%
377,735 $29.1 Million
Q4 2020

Feb 16, 2021

SELL
$71.77 - $79.65 $1.59 Million - $1.77 Million
-22,200 Reduced 6.06%
344,135 $28.2 Million
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $16.1 Million - $18.3 Million
220,100 Added 150.51%
366,335 $30.4 Million
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $471,814 - $536,871
6,700 Added 4.8%
146,235 $11.3 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $49.4 Million - $68.4 Million
-779,000 Reduced 84.81%
139,535 $10.7 Million
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $19 Million - $21.4 Million
-244,600 Reduced 21.03%
918,535 $83.5 Million
Q3 2019

Nov 14, 2019

SELL
$76.08 - $82.93 $3.1 Million - $3.38 Million
-40,800 Reduced 3.39%
1,163,135 $97.9 Million
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $659,988 - $771,025
-9,450 Reduced 0.78%
1,203,935 $101 Million
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $3.08 Million - $3.51 Million
44,200 Added 3.78%
1,213,385 $101 Million
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $59.4 Million - $68.9 Million
910,650 Added 352.23%
1,169,185 $89.3 Million
Q3 2018

Nov 13, 2018

BUY
$57.69 - $67.84 $1.34 Million - $1.57 Million
23,200 Added 9.86%
258,535 $18.3 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $672,989 - $790,692
-13,240 Reduced 5.33%
235,335 $14.3 Million
Q1 2018

May 15, 2018

SELL
$50.96 - $59.23 $254,800 - $296,150
-5,000 Reduced 1.97%
248,575 $13.5 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $1.67 Million - $2 Million
32,370 Added 14.63%
253,575 $14.3 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $13 Million - $14 Million
221,205
221,205 $14.2 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.